![](https://www.optiknow.ca/wp-content/uploads/2015/11/Novartis_alcon-logo-1.jpg)
Novartis Delivered Solid 2016 Performance, Alcon Q4 Sales Flat
Thursday, February 2 2017 | 00 h 00 min | Financial News
Sales were in line with last fiscal year due to strong performances from growth products (Cosentyx, Entresto, Gilenya, oncology, Sandoz...
Read More![](https://www.optiknow.ca/wp-content/uploads/2016/12/Novartis_encore-logo-1.jpg)
Novartis to Acquire Presbyopia Drug Developer Encore Vision
Wednesday, December 21 2016 | 00 h 00 min | Agreements and Acquisitions, News, Press Release
Novartis Ophthalmology announced they have entered into an agreement to acquire a topical treatment for presbyopia from Encore Vision Inc, a...
Read More![](https://www.optiknow.ca/wp-content/uploads/2015/11/Novartis_alcon-logo-1.jpg)
Novartis on Alcon: All Options are Open
Monday, November 14 2016 | 00 h 00 min | News
Reuters reported yesterday, that Swiss parent of Alcon, drugmaker Novartis is considering the sale of its eye care unit Alcon The source is an...
Read More![](https://www.optiknow.ca/wp-content/uploads/2015/11/Novartis_alcon-logo-1.jpg)
Alcon Replaces CEO and Restructures After Poor Earnings Report
Thursday, January 28 2016 | 00 h 00 min | News
Following reports of plummeting sales from Alcon’s eye-care unit and news that Novartis will miss its Q4 earnings estimates, Alcon executive Jeff...
Read More![](https://www.optiknow.ca/wp-content/uploads/2015/11/Novartis_alcon-logo-1.jpg)
Novartis Considering Selling Alcon’s CL Care Business
Wednesday, December 2 2015 | 00 h 00 min | News
Bloomberg News is reporting that Novartis is considering selling Alcon’s contact lens care product business While Alcon’s revenues as a whole...
Read More